Volume 57, March 2026, 101056
Author links open overlay panel, , , , , , , , , , , , , , , , , , , AbstractBackgroundMagnesium-based implants facilitate bone regeneration via degradation. However, the epigenetic mechanisms, particularly N6-methyladenosine (m6A) modification regulated by Mg2+, remain incompletely understood. This study investigated the role of Mg2+ in osteogenic differentiation through the METTL3-RhoA axis and evaluated its potential in intervertebral fusion.
MethodsThe optimal Mg2+ concentration was identified using MC3T3-E1 cells. Methylated RNA immunoprecipitation sequencing (MeRIP-seq) and MeRIP-PCR were employed to identify m6A target genes. Functional assays (knockdown, overexpression, and rescue) validated the METTL3-YTHDF1-RhoA pathway. A rat tail intervertebral fusion model with magnesium implants was used to assess in vivo effects.
ResultsTreatment with 4 mM Mg2+ significantly enhanced osteogenic activity and increased METTL3 levels. Mechanistically, METTL3 promoted m6A methylation of RhoA mRNA, which was subsequently bound by YTHDF1, enhancing translation and activating the RhoA/ROCK pathway. In vivo, magnesium implants accelerated fusion and improved trabecular bone quality; however, these effects were inhibited by METTL3 or RhoA inhibitors.
ConclusionMg2+ enhances osteogenic differentiation through the METTL3-YTHDF1-RhoA/ROCK pathway.
The translational potential of this articleThis study provides an epigenetic framework for optimizing magnesium-based orthopedic implants and suggests that targeting the m6A-RhoA axis could improve spinal fusion outcomes.
Graphical abstractGraphical Abstract: Magnesium ions upregulate METTL3 expression, enhancing m6A modification on RhoA mRNA. The m6A reader YTHDF1 recognizes and binds to the modified sites, promoting RhoA translation. This activates the RhoA/ROCK signaling pathway, ultimately driving osteogenic differentiation, bone remodeling, and intervertebral fusion.
Download: Download high-res image (310KB)Download: Download full-size imageKeywordsIntervertebral fusion
Magnesium ions
METTL3
m6A modification
Osteogenic differentiation
RhoA/ROCK pathway
© 2026 The Author(s). Published by Elsevier B.V. on behalf of Chinese Speaking Orthopaedic Society.
Comments (0)